Pharmacokinetic Study to Evaluate Progesterone Vaginal Rings

Study Title

A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women

Teva Identifier

DR201-BE-10021

ClinicalTrials.gov Identifier

NCT02092571

Study Status

Completed

Trial Condition(s)

Pharmacokinetics

Interventions

Drug: Progesterone vaginal ring,

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
female icon for clinical trials

Key Participation Requirements

Gender

Female

Age Range

40 Years to 70 Years

Trial Duration

02/01/2014 - 08/01/2014

Phase

Phase 1

Study Type

Interventional